162 related articles for article (PubMed ID: 28102032)
1. Nonpromoter methylation of the CDKN2A gene with active transcription is associated with improved locoregional control in laryngeal squamous cell carcinoma.
Ben-Dayan MM; Ow TJ; Belbin TJ; Wetzler J; Smith RV; Childs G; Diergaarde B; Hayes DN; Grandis JR; Prystowsky MB; Schlecht NF
Cancer Med; 2017 Feb; 6(2):397-407. PubMed ID: 28102032
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma.
Schlecht NF; Ben-Dayan M; Anayannis N; Lleras RA; Thomas C; Wang Y; Smith RV; Burk RD; Harris TM; Childs G; Ow TJ; Prystowsky MB; Belbin TJ
Cancer Med; 2015 Mar; 4(3):342-53. PubMed ID: 25619363
[TBL] [Abstract][Full Text] [Related]
3. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
4. Alterations of p14
López F; Sampedro T; Llorente JL; Hermsen M; Álvarez-Marcos C
Pathol Oncol Res; 2017 Jan; 23(1):63-71. PubMed ID: 27377733
[TBL] [Abstract][Full Text] [Related]
5. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
6. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
7. Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.
Wijetunga NA; Belbin TJ; Burk RD; Whitney K; Abadi M; Greally JM; Einstein MH; Schlecht NF
Gynecol Oncol; 2016 Sep; 142(3):566-73. PubMed ID: 27401842
[TBL] [Abstract][Full Text] [Related]
8. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
9. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.
Tang S; Luo H; Yu J; Yang D; Shu J
Chin Med J (Engl); 2003 Jul; 116(7):1083-7. PubMed ID: 12890389
[TBL] [Abstract][Full Text] [Related]
10. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.
Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK
J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882
[TBL] [Abstract][Full Text] [Related]
11. Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression.
Ming Z; Lim SY; Rizos H
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33076392
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
[TBL] [Abstract][Full Text] [Related]
13. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.
Kresty LA; Mallery SR; Knobloch TJ; Song H; Lloyd M; Casto BC; Weghorst CM
Cancer Res; 2002 Sep; 62(18):5295-300. PubMed ID: 12234999
[TBL] [Abstract][Full Text] [Related]
14. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
15. Genetic and methylation status of CDKN2A (p14
Chantre-Justino M; Gonçalves da Veiga Pires I; Cardoso Figueiredo M; Dos Santos Moreira A; Alves G; Faria Ornellas MH
Hum Pathol; 2022 Jan; 119():94-104. PubMed ID: 34826422
[TBL] [Abstract][Full Text] [Related]
16. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
[TBL] [Abstract][Full Text] [Related]
17. Loss of p16
Aesif SW; Aubry MC; Yi ES; Kloft-Nelson SM; Jenkins SM; Spears GM; Greipp PT; Sukov WR; Roden AC
J Thorac Oncol; 2017 May; 12(5):860-871. PubMed ID: 28179162
[TBL] [Abstract][Full Text] [Related]
18. Inverse association of p16 INK4a and p14 ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer.
Verdoodt B; Sommerer F; Palisaar RJ; Noldus J; Vogt M; Nambiar S; Tannapfel A; Mirmohammadsadegh A; Neid M
Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):295-301. PubMed ID: 21912429
[TBL] [Abstract][Full Text] [Related]
19. P16(INK⁴a) overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomas.
Larque AB; Conde L; Hakim S; Alos L; Jares P; Vilaseca I; Cardesa A; Nadal A
Virchows Arch; 2015 Apr; 466(4):375-82. PubMed ID: 25652585
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
